Viewing Study NCT02960594

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-03-05 @ 7:52 PM
Study NCT ID: NCT02960594
Status: COMPLETED
Last Update Posted: 2018-11-19
First Post: 2016-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse
Sponsor: Inovio Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None Lung Cancer View
None Pancreatic Cancer View
None Head and Neck Cancer View
None Ovarian Cancer View
None ColoRectal Cancer View
None Gastric Cancer View
None Esophageal Cancer View
None HepatoCellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Human Telomerase Reverse Transcriptase (hTERT) View
None Breast Neoplasms View
None Lung Neoplasms View
None Pancreatic Neoplasms View
None High Risk of Relapse View
None Post Definitive Surgery View
None Post Adjuvant Therapy View
None No Evidence of Disease View